Obeticholic Acid/Bezafibrate

奥贝胆酸/苯扎贝特

Report date: 2025/11/18 20:00:06

Base Information

Drug NameObeticholic Acid/Bezafibrate
Drug Alias NameFDCOCA/BZF
ClassificationSmall molecules
Mechanisms of ActionBile acid receptor FXR agonistsPeroxisome proliferator activated receptor agonists
TargetsBile acid receptor FXRPeroxisome proliferator activated receptor
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[21
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntercept Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCholangitis, Sclerosing

Other Information

ATC CodeN/A
Related LinksN/A